| NCT ID | NCT02038127 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yonsei University |
| Condition | Coronary Artery Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2013-01-01 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2013-01-01 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective, multicenter registry will consecutively enroll patients of all ages undergoing percutaneous coronary intervention (PCI) at four university hospitals in Gangwon Province, Republic of Korea. The study will describe contemporary clinical, procedural, and medication treatment patterns and assess 1-year clinical outcomes in routine practice. The primary outcome is patient-oriented composite outcome (POCO), defined as all-cause death, any myocardial infarction, or any repeat revascularization. No study-specific intervention will be assigned.
Eligibility Criteria
Inclusion Criteria: * Patients of any age undergoing percutaneous coronary intervention (PCI) at a participating hospital during the study period. * Written informed consent is obtained from the patient or a legally authorized representative before collection of study data, unless the requirement for informed consent is waived by the Institutional Review Board. Exclusion Criteria: * Refusal or withdrawal of informed consent, when informed consent is required. * No PCI performed during the index hospital encounter.
Contact & Investigator
Young Jin Youn, M.D., Ph.D.
PRINCIPAL INVESTIGATOR
Yonsei University
Frequently Asked Questions
Who can join the NCT02038127 clinical trial?
This trial is open to participants of all sexes, studying Coronary Artery Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02038127 currently recruiting?
Yes, NCT02038127 is actively recruiting participants. Contact the research team at younyj@yonsei.ac.kr for enrollment information.
Where is the NCT02038127 trial being conducted?
This trial is being conducted at Chuncheon, South Korea, Chuncheon, South Korea, Gangneung, South Korea, Wŏnju, South Korea.
Who is sponsoring the NCT02038127 clinical trial?
NCT02038127 is sponsored by Yonsei University. The principal investigator is Young Jin Youn, M.D., Ph.D. at Yonsei University. The trial plans to enroll 10,000 participants.